Skip to search formSkip to main contentSkip to account menu

Autologous Dendritic Cell-based Immunotherapeutic AV0113

Known as: AV0113 DC-CIT, AV0113, AV0113 Dendritic Cell Cancer Immunotherapeutic 
A therapeutic interleukin-12 (IL-12)-expressing dendritic cell (DC)-based vaccine composed of autologous monocyte-derived DCs loaded with autologous… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
A randomized clinical trial for the treatment of glioblastoma multiforme with the individualized dendritic cell-based cancer immunotherapy AV0113.
2052 Background: We recruited 78 patients aged 18-70 years suffering from newly diagnosed glioblastoma multiforme (GBM) into a… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)